Cargando…

Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals

BACKGROUND: HIV-1 infection increases plasma levels of inflammatory markers. Combination antiretroviral therapy (cART) does not restore inflammatory markers to normal levels. Since intensification of cART with raltegravir reduced CD8 T-cell activation in the Discor-Ral and IntegRal studies, we have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Massanella, Marta, Ouchi, Dan, Marfil, Silvia, Llibre, Josep M., Puertas, Maria C., Buzón, María J., Richman, Douglas D., Orna, Elisa, Stevenson, Mario, Gatell, Josep M., Domingo, Pere, Negredo, Eugènia, Martinez-Picado, Javier, Clotet, Bonaventura, Blanco, Julià
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252101/ https://www.ncbi.nlm.nih.gov/pubmed/25462535 http://dx.doi.org/10.1371/journal.pone.0114142

Ejemplares similares

Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
por: Buzón, Maria J., et al.
Publicado: (2011)

Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART
por: Puertas, Maria C., et al.
Publicado: (2016)

Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals
por: Kawana-Tachikawa, Ai, et al.
Publicado: (2014)

Prevalence of Ischemic Heart Disease and Management of Coronary Risk in Daily Clinical Practice: Results from a Mediterranean Cohort of HIV-Infected Patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs
por: Puertas, Maria C, et al.
Publicado: (2018)

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery
por: Massanella, Marta, et al.
Publicado: (2015)

Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
por: Santos, José R., et al.
Publicado: (2012)

Antiretroviral therapy suppressed participants with low CD4(+) T-cell counts segregate according to opposite immunological phenotypes
por: Pérez-Santiago, Josué, et al.
Publicado: (2016)

Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Modelling HIV-1 2-LTR dynamics following raltegravir intensification
por: Luo, Rutao, et al.
Publicado: (2013)

Low levels of anti-MPER antibodies are detectable in viremic HIV infected
por: Carrillo, J, et al.
Publicado: (2012)

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome
por: Curriu, Marta, et al.
Publicado: (2013)

On the steps of cell-to-cell HIV transmission between CD4 T cells
por: Puigdomènech, Isabel, et al.
Publicado: (2009)

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner
por: Echeverría, Patricia, et al.
Publicado: (2014)

Association between lipid genetic and immunological status in chronically HIV-infected patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy
por: Gálvez, Cristina, et al.
Publicado: (2021)

Remote Health Monitoring in the Workplace for Early Detection of COVID-19 Cases during the COVID-19 Pandemic Using a Mobile Health Application: COVIDApp.
por: Echeverría, Patricia, et al.
Publicado: (2021)

Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial
por: van Lelyveld, Steven F. L., et al.
Publicado: (2015)

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
por: Llibre, Josep M, et al.
Publicado: (2013)

The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein
por: Rodriguez-Plata, Maria T, et al.
Publicado: (2013)

HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4
por: Puigdomènech, Isabel, et al.
Publicado: (2008)

Restricted infection of xenotropic murine leukemia virus-related virus in human lymphoid tissue
por: Curriu, Marta, et al.
Publicado: (2011)

Hidden costs of antiretroviral treatment: the public health efficiency of drug packaging
por: Andreu-Crespo, Àngels, et al.
Publicado: (2015)

High Prevalence of Sarcopenia in HIV-Infected Individuals
por: Echeverría, Patricia, et al.
Publicado: (2018)

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors
por: Felip, Eudald, et al.
Publicado: (2022)

Virological Efficacy in Cerebrospinal Fluid and Neurocognitive Status in Patients with Long-Term Monotherapy Based on Lopinavir/Ritonavir: An Exploratory Study
por: Santos, José R., et al.
Publicado: (2013)

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity
por: Bonjoch, Anna, et al.
Publicado: (2016)

Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014)

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia
por: Llibre, Josep M., et al.
Publicado: (2015)

IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation
por: Ezeonwumelu, Ifeanyi Jude, et al.
Publicado: (2022)

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
por: Negredo, Eugènia, et al.
Publicado: (2020)

Enhancement of Antiviral CD8(+) T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab
por: Blanch-Lombarte, Oscar, et al.
Publicado: (2019)

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men
por: Fumaz, Carmina R., et al.
Publicado: (2016)

Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence
por: Martinez-Picado, Javier, et al.
Publicado: (2018)

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals
por: Juega-Mariño, Javier, et al.
Publicado: (2017)

Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals
por: Carrillo, Jorge, et al.
Publicado: (2015)

Aging in HIV-Infected Subjects: A New Scenario and a New View
por: Negredo, Eugenia, et al.
Publicado: (2017)

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients
por: Podzamczer, Daniel, et al.
Publicado: (2014)

The Genome-wide Methylation Profile of CD4(+) T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression
por: Moron-Lopez, Sara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o043mk58vnut49sdk5j1i3ro64